Rule 4729:8-2-02 | Additional drugs to be reported.
(A) Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription, personally furnished by a prescriber, or sold at wholesale to a prescriber or terminal distributor of dangerous drugs shall be submitted to the state board of pharmacy in accordance with sections 4729.77, 4729.78 and 4729.79 of the Revised Code and this division of the Administrative Code:
All dangerous drug products containing gabapentin.
(B) Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription shall be submitted to the state board of pharmacy in accordance with section 4729.77 of the Revised Code and this division of the Administrative Code:
All dangerous drug products containing naltrexone that are indicated for the treatment of alcohol dependence or the prevention of relapse to opioid dependence.
Last updated September 11, 2023 at 11:40 AM
Supplemental Information